ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,761Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1479

$578K Total Retail Price of All Prescriptions

Rank: 34 out of 1479

676 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 12,839 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 777 707 1 1
LOSARTAN-HYDROCHLOROTHIAZIDE 527 460 2 14
GABAPENTIN 517 427 3 5
LOSARTAN POTASSIUM 492 439 4 8
RANITIDINE HCL 471 396 5 4
ENALAPRIL MALEATE 436 378 6 3
METFORMIN HCL 393 328 7 2
OMEPRAZOLE 354 306 8 7
AMLODIPINE BESYLATE 331 303 9 6
GLIMEPIRIDE 309 277 10 21
ATENOLOL 299 292 11 11
LEVOTHYROXINE SODIUM 291 233 12 9
HYDROCHLOROTHIAZIDE 255 223 13 10
AZITHROMYCIN 243 198 14 25
ZOLPIDEM TARTRATE 225 206 15 23
SYNTHROID 214 188 16 12
DICLOFENAC SODIUM 213 182 17 68
FLUTICASONE PROPIONATE 191 153 18 64
SERTRALINE HCL 189 156 19 38
PANTOPRAZOLE SODIUM 186 160 20 48
LANTUS 184 149 21 35
FUROSEMIDE 182 163 22 15
ATORVASTATIN CALCIUM 179 147 23 41
TRAMADOL HCL 159 140 24 20
DEXAMETHASONE 136 110 25 60
ALENDRONATE SODIUM 133 127 26 19
GLIPIZIDE 130 121 27 13
CETIRIZINE HCL 125 110 28 155
DONEPEZIL HCL 115 114 29 45
TRAMADOL HCL-ACETAMINOPHEN 114 105 30 18
HUMALOG 110 88 31 169
CLOPIDOGREL 108 93 32 46
METOPROLOL SUCCINATE 101 99 33 51
CAPTOPRIL 100 86 34 28
MECLIZINE HCL 100 78 34 50
CIPROFLOXACIN HCL 100 90 34 26
METOPROLOL TARTRATE 96 91 37 17
NAMENDA 95 94 38 69
ASPIRIN EC 95 79 38 24
JANUMET 93 89 40 120
ISOSORBIDE MONONITRATE ER 92 92 41 31
TAMSULOSIN HCL 91 91 42 36
CARAFATE 91 76 42 196
ETODOLAC 90 77 44 75
CLOTRIMAZOLE-BETAMETHASONE 90 78 44 39
RAMIPRIL 89 83 46 63
INSULIN SYRINGE 87 78 47 30
LISINOPRIL 86 73 48 16
PLAVIX 77 72 49 52
LANSOPRAZOLE 74 62 50 92
CARVEDILOL 73 72 51 32
AMLODIPINE BESYLATE-BENAZEPRIL 66 66 52 54
GEMFIBROZIL 65 50 53 49
PRAVASTATIN SODIUM 65 58 53 27
DOXAZOSIN MESYLATE 61 61 55 33
JANUVIA 60 51 56 107
FINASTERIDE 60 60 56 84
QUETIAPINE FUMARATE 58 45 58 108
ENALAPRIL-HYDROCHLOROTHIAZIDE 55 47 59 160
FAMOTIDINE 54 43 60 47
CELEBREX 54 50 60 206
GLYBURIDE-METFORMIN HCL 52 51 R 62 53
SINGULAIR 51 26 63 74
FENOFIBRATE 50 45 64 37
PENTOXIFYLLINE 50 50 64 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.